当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3759856
自主品牌
已选条件
-
T2377Pilaralisib analogueXL147 analogue；SAR245408
XL147 analogue is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.
价 格：￥电议型 号：T2377产 地：中国大陆
-
T2365PilaralisibXL-147；SAR245408
Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, am
价 格：￥电议型 号：T2365产 地：中国大陆
-
T2365PilaralisibPilaralisib,SAR245408,XL-147
Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, am
价 格：￥电议型 号：T2365产 地：美洲
-
T2377Pilaralisib analogue化合物XL147 analogueXL147 analogue|||SAR245408
Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.
价 格：￥电议型 号：T2377产 地：中国大陆
-
T2365Pilaralisib；化合物PilaralisibSAR245408|||XL-147；SAR245408|||XL-147
Pilaralisib (XL-147) is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
价 格：￥电议型 号：T2365产 地：中国大陆
